Citigroup’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90.1K | Sell |
13,406
-5,180
| -28% | -$34.8K | ﹤0.01% | 3731 |
|
|
2025
Q1 | $168K | Sell |
18,586
-1,292
| -6% | -$11.7K | ﹤0.01% | 3534 |
|
|
2024
Q4 | $344K | Buy |
19,878
+1,896
| +11% | +$32.8K | ﹤0.01% | 3251 |
|
|
2024
Q3 | $287K | Buy |
17,982
+12,439
| +224% | +$199K | ﹤0.01% | 3348 |
|
|
2024
Q2 | $79K | Sell |
5,543
-50,744
| -90% | -$723K | ﹤0.01% | 3604 |
|
|
2024
Q1 | $798K | Buy |
56,287
+53,177
| +1,710% | +$754K | ﹤0.01% | 2532 |
|
|
2023
Q4 | $46.9K | Buy |
3,110
+3,079
| +9,932% | +$46.5K | ﹤0.01% | 3809 |
|
|
2023
Q3 | $490 | Sell |
31
-6,632
| -100% | -$105K | ﹤0.01% | 4449 |
|
|
2023
Q2 | $101K | Sell |
6,663
-55,360
| -89% | -$838K | ﹤0.01% | 3575 |
|
|
2023
Q1 | $899K | Buy |
62,023
+10,981
| +22% | +$159K | ﹤0.01% | 2094 |
|
|
2022
Q4 | $690K | Buy |
51,042
+49,459
| +3,124% | +$669K | ﹤0.01% | 2316 |
|
|
2022
Q3 | $25K | Buy |
1,583
+1,489
| +1,584% | +$23.5K | ﹤0.01% | 3946 |
|
|
2022
Q2 | $1K | Sell |
94
-319
| -77% | -$3.39K | ﹤0.01% | 5285 |
|
|
2022
Q1 | $4K | Sell |
413
-1,980
| -83% | -$19.2K | ﹤0.01% | 5092 |
|
|
2021
Q4 | $41K | Buy |
+2,393
| New | +$41K | ﹤0.01% | 4398 |
|